Medical Condition News

RSS

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.

9 Oct 2014

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

9 Oct 2014

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Heart attack survivors often experience dangerous heart rhythm disturbances during treatment designed to restore blood flow to the injured heart muscle, a common and confounding complication of an otherwise lifesaving intervention.

9 Oct 2014

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

9 Oct 2014

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.

9 Oct 2014

Academy of Nutrition and Dietetics applauds USPSTF's recommendations on screening for diabetes

The Academy of Nutrition and Dietetics applauds the work of the United States Preventative Services Task Force for amending its recommendations on screening for diabetes based on its review of current best evidence.

9 Oct 2014

Women with healthy diet and lifestyle less likely to have stroke

Women with a healthy diet and lifestyle may be less likely to have a stroke by more than half, according to a study published in the October 8, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Oct 2014

Temple researchers to create awareness about healthy diet among low-income Asian Americans

Although low-income Asian Americans are at a high risk for diabetes, hypertension, heart attack and stroke, they are under a misconception that their diet is healthy and not a risk factor for these chronic diseases.

9 Oct 2014

Bad sleep quality may trigger insomnia in older adults

Reports of insomnia are common among the elderly, but a new study finds that sleep problems may stem from the quality of rest and other health concerns more than the overall amount of sleep that patients get.

9 Oct 2014

Discovery could lead to treatments for alcohol-related liver diseases

Researchers at the University of Missouri School of Medicine have identified epigenetic protein changes caused by binge drinking, a discovery that could lead to treatments for alcohol-related liver diseases.

9 Oct 2014

BRCA mutations carry risks for salivary gland cancer, breast cancer

The risk of developing cancer in a salivary gland might be higher in people with mutations in either of two genes associated with breast and ovarian cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

9 Oct 2014

UCI to receive $8 million from NIH to study brain cell activity in motor neuron disorders

UC Irvine will receive $8 million from the National Institutes of Health to establish one of six national centers dedicated to creating a database of human cellular responses that will accelerate efforts to develop new therapies for many diseases.

9 Oct 2014

AT2101 drug, evaluated for Gaucher disease, slows progression of Parkinson's disease in mice

A new study from UCLA found that a drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson's disease in mice.

9 Oct 2014

Increased risk of premature death associated with higher BMI similar for African Americans, whites

A study from American Cancer Society researchers finds the increased risk of premature death associated with a higher body mass index (BMI) is similar for African Americans and whites, in contrast to previous, smaller studies that indicated the association may be weaker for African Americans.

9 Oct 2014

Researchers generate fruit fly model, unveil key genetic factors behind human colon cancer

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer. With two publications appearing in PLoS One and EMBO Reports, the IRB team also unveil the function of a key gene in the development of the disease.

9 Oct 2014

NIH announces high-risk, high-reward grants for UCSF researchers

UC San Francisco researchers received five awards announced this week by the National Institutes of Health (NIH) for high-risk, high-reward scientific research projects. Their work will focus on novel approaches for diagnosing and treating diseases ranging from autoimmune and chronic inflammatory diseases, to cancer, diabetes and neurological disorders.

8 Oct 2014

Cancer Network presents exclusive coverage of ESMO 2014 Congress

UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.

8 Oct 2014

Large-scale study results of cardiac arrest cases now available on ScienceDirect

The results of a four-year international study of 2060 cardiac arrest cases across 15 hospitals published and available now on ScienceDirect.

8 Oct 2014

Magnesium essential to the activity of vitamin D

Extensive research has shown that vitamin D deficiencies play a major role in the development of dozens of diseases, including breast, prostate and colon cancer, as well as diabetes, heart disease, arthritis, osteoporosis, psoriasis and mental illness.

8 Oct 2014

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).

8 Oct 2014

Medical Condition News

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Academy of Nutrition and Dietetics applauds USPSTF's recommendations on screening for diabetes

Women with healthy diet and lifestyle less likely to have stroke

Temple researchers to create awareness about healthy diet among low-income Asian Americans

Bad sleep quality may trigger insomnia in older adults

Discovery could lead to treatments for alcohol-related liver diseases

BRCA mutations carry risks for salivary gland cancer, breast cancer

UCI to receive $8 million from NIH to study brain cell activity in motor neuron disorders

AT2101 drug, evaluated for Gaucher disease, slows progression of Parkinson's disease in mice

Increased risk of premature death associated with higher BMI similar for African Americans, whites

Researchers generate fruit fly model, unveil key genetic factors behind human colon cancer

NIH announces high-risk, high-reward grants for UCSF researchers

Cancer Network presents exclusive coverage of ESMO 2014 Congress

Large-scale study results of cardiac arrest cases now available on ScienceDirect

Magnesium essential to the activity of vitamin D

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News